Case Snapshot

JANSSEN PHARMACEUTICALS, INC f/k/a JANSSEN PHARMACEUTICA INC. f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC et al (docket 22-cv-02987) remains pending in the District of New Jersey E1.

Key Developments

Major Updates

  • The litigation involves multiple plaintiffs, including Carson, who filed against Janssen Pharmaceuticals, Inc.
  • The case is part of a broader pattern of filings against the company, with at least seven similar cases receiving court orders on May 6, 2026 E4.
  • What the Court Said On May 6, 2026, the District of New Jersey issued orders of dismissal in multiple cases involving Janssen Pharmaceuticals, Inc.
  • f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • JANSSEN PHARMACEUTICALS, INC (2:22-cv-02987), which received an order of dismissal with reference to rule 4 E24 E25.

Legal Context

JANSSEN PHARMACEUTICALS, INC (2:22-cv-03300) and ARREDONDO v. JANSSEN PHARMACEUTICALS, INC (2:22-cv-03030), each receiving identical dismissal references E7 E10.

The court issued at least seven such orders on the same date, with some dismissals citing rule 4 and others rule 6 E19 E25. The pattern of dismissals suggests coordinated legal strategy by Janssen Pharmaceuticals, Inc.

At least 10 cases show shared legal vocabulary overlaps, indicating potential common defense arguments E36 E38. The dismissals occurred across different districts, including the District of New Jersey and others with docket numbers like 26-cv-04894 and 21-cv-20218 E36 E38.

What Comes Next

Plaintiffs in these cases included individuals like NOLTING, ADAMS, and DEMOTTE, who all faced similar procedural outcomes E29 E30 E32.

The dismissals may signal procedural challenges for plaintiffs seeking to litigate against pharmaceutical companies, as courts appear to be applying standardized dismissal protocols E6. The dismissals in these cases may lead to appeals or re-filings by plaintiffs.

The court's use of identical dismissal references across multiple cases suggests potential for consolidated review.

What The Record Shows

Docket Record

  • The case "CARSON v. JANSSEN PHARMACEUTICALS, INC f/k/a JANSSEN PHARMACEUTICA INC. f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC et al" (docket 22-cv-02987) is pending before District of New Jersey E1.
  • The District of New Jersey has issued a flurry of orders in a series of cases against Janssen Pharmaceuticals, Inc. f/k/a Janssen Pharmaceutica Inc. f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc E3.
  • On May 6, 2026, the court issued orders in at least seven cases, including Carson v E4.
  • The orders appear to be related to the dismissal of the cases, but the specifics are unclear E6.

Parties And Court

  • 2:22-cv-02987 CARSON appears in this matter as Plaintiff E28.
  • 2:22-cv-03007 NOLTING appears in this matter as Plaintiff E29.
  • 2:22-cv-03027 ADAMS appears in this matter as Plaintiff E30.
  • 2:22-cv-03030 ARREDONDO appears in this matter as Plaintiff E31.
  • 2:22-cv-03036 DEMOTTE appears in this matter as Plaintiff E32.
  • 2:22-cv-03299 ARMSTRONG appears in this matter as Plaintiff E33.

Additional Record Notes

  • On 2026-05-06, Order: 2:22-cv-03300 ASCHERMANN v. JANSSEN PHARMACEUTICALS, INC f/k/a JANSSEN PHARMACEUTICA INC. f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC et al E7.
  • On 2026-05-06, Order: 2:22-cv-03030 ARREDONDO v. JANSSEN PHARMACEUTICALS, INC f/k/a JANSSEN PHARMACEUTICA INC. f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC et al E10.
smart_toy Juryvine article generated from court filings and verified news coverage. How we verify our work.